Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, October 01, 2014
 
Register | Sign in
Home Page>Products
  Product News
3D Triculture Model for Evaluating Breast Cancer Progression
Wednesday, October 01, 2014
New application note introduces a more predictive and realistic model for drug screening of cancer therapeutics.

An Innovative Solution for Confocal Super Resolution
Wednesday, October 01, 2014
With the new Olympus FV-OSR software, the FluoView FV1200 is transformed into a powerful system for confocal Super Resolution microscopy.

Bosch Introduces CIP System for Use with Human Vaccines
Wednesday, October 01, 2014
Closed system for high operator protection.

Phenomenex Kinetex® EVO Core-Shell HPLC Columns
Wednesday, October 01, 2014
Deliver improved results and stability from pH 1 to 12.

Agilent Technologies’ Next-Generation UHPLC System
Tuesday, September 30, 2014
The 1290 Infinity II LC system sets new benchmark in laboratory efficiency.

New Line of XPE Balances from Mettler Toledo
Tuesday, September 30, 2014
The new XPE balances deliver accurate, compliant results and provide users with a high level of process security, suitable for even the strictest regulations.

New Mosaic 6.0 Makes Sample Management More Intuitive and Cost-effective
Tuesday, September 30, 2014
Latest version of Titian’s Mosaic software drives major increase in sample management efficiency.

Digitron Extends its Range of High Quality Hand-Held Digital Thermometers
Tuesday, September 30, 2014
Offers speed, accuracy and performance at an affordable price.

Bioo Scientific Improves Sensitivity and Reliability of Tetracycline Detection
Tuesday, September 30, 2014
New MaxSignal® Tetracycline ELISA Kit with ready-to-use standards.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 10528
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv